Insights on the pathology of kidney stone formation - PubMed (original) (raw)

Review

Insights on the pathology of kidney stone formation

Andrew P Evan et al. Urol Res. 2005 Nov.

Abstract

The purpose of these studies was to test the hypothesis that Randall's plaque develops in unique anatomical sites of the kidney and that its formation is conditioned by specific stone-forming pathophysiologies. To test this hypothesis, we performed intraoperative mapping studies with biopsies of papilla from the kidneys of 15 idiopathic calcium oxalate (CaOx) stone formers, four intestinal bypass for obesity patients and ten brushite stone formers, and obtained papillary specimens from four non-stone formers after nephrectomy. Both light and electron microscopic examination of tissue changes along with infrared and electron diffraction analyses of mineral composition were performed. Distinct patterns of mineral deposition and papillary pathology were discovered in each of the three different stone forming groups. CaOx stone formers had predictable sites of interstitial apatite crystals beginning at the thin loops of Henle and spreading to the urothelium. These plaque areas are termed Randall's plaque and are thought to serve as sites for stone attachment. The papilla and medullary tubules appeared normal. The intestinal bypass patients only had intraluminal sites of crystalline material in the medullary collecting ducts. The brushite stone formers had the most severe form of cortical and medullary changes with sites of Randall's plaque, and yellowish intraluminal deposits in medullary collecting ducts. All deposits were determined to be apatite. The metabolic and surgical pathologic finding in three distinct groups of stone formers clearly shows that "the histology of the renal papilla from a stone former is particular to the clinical setting". It is observations like these that we believe will provide the insights to allow the stone community to generate better clinical treatments for kidney stone disease, as we understand the pathogenesis of stone formation for each type of stone former.

PubMed Disclaimer

Similar articles

• Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.
  Evan A, Lingeman J, Coe FL, Worcester E. Evan A, et al. Kidney Int. 2006 Apr;69(8):1313-8. doi: 10.1038/sj.ki.5000238. Kidney Int. 2006. PMID: 16614720 Review.
• Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.
  Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Evan AP, et al. J Clin Invest. 2003 Mar;111(5):607-16. doi: 10.1172/JCI17038. J Clin Invest. 2003. PMID: 12618515 Free PMC article.
• Crystal-associated nephropathy in patients with brushite nephrolithiasis.
  Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. Evan AP, et al. Kidney Int. 2005 Feb;67(2):576-91. doi: 10.1111/j.1523-1755.2005.67114.x. Kidney Int. 2005. PMID: 15673305
• Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
  Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM. Evan AP, et al. Anat Rec (Hoboken). 2008 Mar;291(3):325-34. doi: 10.1002/ar.20656. Anat Rec (Hoboken). 2008. PMID: 18286613
• The role of Randall's plaques in the pathogenesis of calcium stones.
  Matlaga BR, Coe FL, Evan AP, Lingeman JE. Matlaga BR, et al. J Urol. 2007 Jan;177(1):31-8. doi: 10.1016/j.juro.2006.08.088. J Urol. 2007. PMID: 17161996 Review.

Cited by

• Geobiology reveals how human kidney stones dissolve in vivo.
  Sivaguru M, Saw JJ, Williams JC Jr, Lieske JC, Krambeck AE, Romero MF, Chia N, Schwaderer AL, Alcalde RE, Bruce WJ, Wildman DE, Fried GA, Werth CJ, Reeder RJ, Yau PM, Sanford RA, Fouke BW. Sivaguru M, et al. Sci Rep. 2018 Sep 13;8(1):13731. doi: 10.1038/s41598-018-31890-9. Sci Rep. 2018. PMID: 30213974 Free PMC article.
• Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept.
  Wu CY, Martel J, Young D, Young JD. Wu CY, et al. PLoS One. 2009 Nov 30;4(11):e8058. doi: 10.1371/journal.pone.0008058. PLoS One. 2009. PMID: 19956594 Free PMC article.
• Osteogenic-Like Microenvironment of Renal Interstitium Induced by Osteomodulin Contributes to Randall's Plaque Formation.
  Zhu Z, Huang F, Gao M, Liu M, Zhang Y, Tang L, Wu J, Yu H, He C, Chen J, Yang Z, Chen Z, Li Y, Chen H, Lei T, Zeng F, Cui Y. Zhu Z, et al. Adv Sci (Weinh). 2024 Oct;11(40):e2405875. doi: 10.1002/advs.202405875. Epub 2024 Sep 3. Adv Sci (Weinh). 2024. PMID: 39225583 Free PMC article.
• Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study.
  Reiner AP, Kahn A, Eisner BH, Pletcher MJ, Sadetsky N, Williams OD, Polak JF, Jacobs DR Jr, Stoller ML. Reiner AP, et al. J Urol. 2011 Mar;185(3):920-5. doi: 10.1016/j.juro.2010.10.086. Epub 2011 Jan 19. J Urol. 2011. PMID: 21251678 Free PMC article.
• p38 MAPK mediates calcium oxalate crystal-induced tight junction disruption in distal renal tubular epithelial cells.
  Peerapen P, Thongboonkerd V. Peerapen P, et al. Sci Rep. 2013;3:1041. doi: 10.1038/srep01041. Epub 2013 Jan 9. Sci Rep. 2013. PMID: 23304432 Free PMC article.

References

1. 1. J Urol. 1987 Sep;138(3):485-90 - PubMed
2. 1. Kidney Int. 1994 Jun;45(6):1722-30 - PubMed
3. 1. J Urol. 2005 Jan;173(1):117-9; discussion 119 - PubMed
4. 1. Kidney Int. 1996 Nov;50(5):1706-12 - PubMed
5. 1. Front Biosci. 2004 May 01;9:1450-82 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer